Phase I/II – Other

632 trials 274 recruiting

Filter these 632 trials by condition, country, sponsor and more.

Open in Search →

A first time in man study to look at the safety of the experimental drug CCS1477 and what effects it has on cancers that affect the blood, b… Recruiting

2024-519498-20-00 Acute Myeloid Leukaemia (AML)/higher-risk Myelodysplast 2025-05-13
Lu177-Dotatate every 16 weeks to reduce adverse events in patients with midgut neuroendocrine tumors Recruiting

2024-517921-14-00 Neuroendocrine tumors of midgut origin 2025-05-07
T-Guard in dcSSc Recruiting

2024-517283-28-00 diffuse cutaneous systemic sclerosis 2025-04-29
Study of Intravenous Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor to Assess Adverse Events and Change in … Recruiting

2024-514465-18-00 Advanced or Metastatic Non-Squamous NSCLC 2025-04-23
Phase I/II study to evaluate the efficacy and safety of bacterial collagenase administered in patients with Peyronie's Disease Recruiting

2023-509621-45-00 Peyronie’s Disease 2025-04-22
Addition of sulfalasazine to chemotherapy for the treatment of AML in the elderly Recruiting

2024-513084-38-00 Recently diagnosed non favorable Acute Myeloid Leukemia 2025-04-15
A Phase 1b/2 study of arfolitixorin as part of 5-fluorouracil-based treatment regimens in the first-line treatment of metastatic colorectal … Recruiting

2024-516802-43-00 metastatic colorectal cancer 2025-04-09
Exploiting the synergistic effect of PARP inhibition with cisplatin and hyperthermia during interval cytoreductive surgery and HIPEC in ovar… Recruiting

2024-519170-39-00 fallopian tube cancer 2025-04-07
Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants with Locally Advanced or Metastatic Cholangiocarc… Recruiting

2024-514261-19-00 Locally advanced, unresectable or metastatic cholangioc 2025-03-24
A safety and efficacy study of RTX001 autologous macrophage therapy in participants with decompensated liver cirrhosis Recruiting

2024-516288-10-00 Liver Cirrhosis 2025-03-21
A Phase I/II with Ruxolitinib in Patients with Myelofibrosis (MF) who are Unresponsive to JAK inhibitors (HEMA-MED) Recruiting

2024-515252-20-00 Myelofibrosis (MF) unresponsive to JAK inhibitors 2025-03-14
A clinical study of MK-6070 and ifinatamab deruxtecan in people with small cell lung cancer (MK-6070-002) Recruiting

2024-517926-25-00 Small cell lung cancer 2025-03-12
Reduction of plasma cells as an approach to reset autoimmunity in rheumatoid arthritis Recruiting

2024-511536-27-00 Rheumatoid arthritis 2025-03-11
A trial to learn if AZD0486 alone or with other anticancer drugs is safe and works in adults with certain blood cancers Recruiting

2024-515034-33-00 Mantle Cell Lymphoma 2025-03-05
CD8 PET imaging in metastatic solid tumours; A phase II, open label, multi-center study of 89Zr-DF-crefmirlimab for CD8 positron emission to… Recruiting

2024-515885-15-00 Patients with metastatic solid tumours, where clinical 2025-03-04
Study of MK-5684-based Therapies in Advanced Prostate Cancer Recruiting

2023-506288-33-00 Metastatic castration resistant prostate cancer (mCRPC) 2025-03-03
A Clinical Trial for Patients with Advanced Cancers Recruiting

2024-515020-36-00 Advanced Solid tumour 2025-02-24
Pomalidomide as an immune-enhancing agent for the control of HIV (PEACH) Recruiting

2024-512797-10-00 HIV-1-infection 2025-02-13
Pan-tumor Study of I-DXd in Subjects with Recurrent or Metastatic Solid Tumors Recruiting

2023-509632-26-00 Recurrent or Metastatic Solid Tumors (endometrial cance 2025-02-11
A seamless, phase 1b/2 multiple ascending dose/proof of concept study of XTMAB-16 in patients with pulmonary sarcoidosis with or without ext… Recruiting

2022-502877-41-01 Pulmonary sarcoidosis with or without extrapulmonary ma 2025-02-10
PET/CT imaging with FAPI as a biomarker for the distinction between predominant active fibrotic and inflammatory phenotypes in patients with… Recruiting

2023-503686-26-02 Progressive Pulmonary Fibrosis (PPF) 2025-01-24
EEN-RICH study Recruiting

2022-503027-10-00 Crohn's disease 2025-01-21
Intraglandular treatment with adipose derived mesenchymal stem cells in patients with xerostomia due to Sjögrens syndrome (ASSIX) Recruiting

2024-516715-25-00 Sjögrens Syndrone 2025-01-21
Ketamine for depression and alcohol use disorder Recruiting

2023-506052-24-00 Depression 2025-01-20